Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.
The healthcare company posted adjusted earnings of $1.31 a share in the second quarter, topping Wall Street's estimate of $1.28
Super Micro Computer is set to unveil its fourth-quarter results soon, with analysts predicting a double-digit earnings surge.
UnitedHealth (UNH) raised its full-year earnings outlook on Thursday as the health insurance giant r
GE Aerospace (NYSE:GE) reported double-digit growth across key second-quarter 2026 metrics and raised its full-year outlook, citing strong commercial services demand, improved operating execution and a backlog that management said provides visibility into the rest of the year. Chairman and CEO Larr
TSMC reports robust Q2 2026 results with significant revenue growth and increased capital expenditures to meet rising demand in advanced technologies.
Abbott Laboratories (NYSE:ABT) delivered stronger-than-expected second-quarter results and increased its full-year earnings guidance, sending its shares about 2. 5% higher in premarket trading.
Abbott (ABT) delivered earnings and revenue surprises of +2.34% and +0.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
GE Aerospace (NYSE:GE) delivered better-than-expected second-quarter results and upgraded its financial guidance for the full year, supported by continued strength in its commercial services business and improving operational performance. The company reported adjusted earnings of $2.
Halliburton's Q2 results might have reflected stronger completion and drilling activity, tempered by Middle East disruptions and rising costs.
Investing.com -- Abbott (NYSE:ABT) shares are trading higher premarket on Thursday after the company reported second-quarter earnings, topping consensus expectations and raising its full-year earnings guidance.
UnitedHealth Stock Rallies as Profit, Revenue Top Wall Street Expectations
TSMC Stock Drops Even as AI Demand Stays Strong
US banks look like they are trying to move to the upside, but this is a market that has a lot of external influences.
The jet engine maker lifted its adjusted EPS forecast to $7.65–$7.85, up from $7.10–$7.40, after revenue climbed 21% in the quarter
U.S. stocks remain deep in the throes of a major rotation heading into the teeth of the second-quarter earnings season, and the traditional August lull that follows, as investors take money from highflying tech sector and spread that cash across a host of old-economy bets. What’s happening alongside that “great rotation,” however, is also interesting, and likely keeping stocks afloat amid the broader tech declines.
The health insurance giant posted adjusted earnings of $6.38 per share, well above Wall Street estimates, and lifted its full-year adjusted profit guidance to $19.50–$20.00 per share
The chipmaker's net income rose 77% year-over-year in the second quarter, beating analyst estimates, as AI chip demand remains strong
Investing.com -- GE Aerospace reported second-quarter results that exceeded analyst expectations and raised its full-year outlook across all metrics, driven by robust commercial services growth.
United Airlines (UAL) raised the low end of its full-year earnings outlook and reported upbeat secon
UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.
Investing.com -- UnitedHealth Group (NYSE:UNH) reported second quarter results that exceeded analyst expectations across earnings, revenue and guidance, sending shares up 7% premarket as investors responded positively to the healthcare giant's improved outlook.
AppLovin is set to report Q2 earnings next month, and analysts project its bottom line will improve by double digits.
Wednesday, J.B. Hunt reported earnings per share of $1.91, up 45% year over year, from sales of $3.5 billion, up 19%.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
